| Systematic (IUPAC) name | |
|---|---|
| N-[4-(4-acetamidophenyl)sulfonylphenyl]acetamide | |
| Clinical data | |
| Trade names | Rodilone Hansolar |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 77-46-3 |
| ATC code | None |
| PubChem | CID 6477 |
| ChemSpider | 6232 |
| UNII | 0GZ72U84TN |
| KEGG | D02751 |
| ChEMBL | CHEMBL154166 |
| Chemical data | |
| Formula | C16H16N2O4S |
| Mol. mass | 332.374 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| Physical data | |
| Melt. point | 290 °C (554 °F) |
| |
|
Acedapsone (INN) is an antimicrobial drug, which also has antimalarial activity.
Acedapsone, or 1399 F, is a diacetyl compound, derived from dapsone. It was synthesized and developed in 1937 by Ernest Fourneau and his team in the pharmaceutical chemistry laboratory of Pasteur Institute[1], and it was marketed as Rodilone by the Rhône-Poulenc company.[2]
It is a long-acting prodrug of dapsone. It is used for treating leprosy.[3]
It crystallises as pale yellow needles from diethyl ether, and as leaflets from dilute ethanol. It is slightly soluble in water.
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)